The Weekly Summary

General-GreeneAugust 4th – August 10th

In the general news, a US general was shot and killed along with other soldiers ambushed on a base in Afghanistan. In Iraq, the ISIS army advanced, forcing President Obama to act and send humanitarian relief and air strikes. In the US, the NCAA voted to finally allow big schools to pay players.

In healthcare business news, Roche acquired Santaris for $450 Million to obtain an RNA-targeting drug. Also, Walgreen (WAG) declined to use the inversion tax-dodging strategy.

On the data front, Amgen (AMGN) met endpoints in a pivotal trial for Kyprolis to treat myeloma.

From the FDA, The Medicines Company (MDCO) received approval for antibiotic Orbactiv.

This entry was posted in - The Weekly Summary. Bookmark the permalink.

Leave a Reply

Your email address will not be published.